siRNA, Anti-DCAF17, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT46391WQ-2OMe)

The product SIRGT46391WQ-2OMe is a type of small interfering RNA (siRNA) that targets DCAF17 gene and regulates the expression of gene. The siRNA interferes with the expression of DCAF17 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001164821.1
Alternative Names C20orf37; C2orf37
Related Diseases Woodhouse-Sakati Syndrome
Purification HPLC
Target Gene
Gene ID 80067
Uniprot ID Q5H9S7
Sub Cat Target Species Modification Scale  
SIRGT47391WQ-2F DCAF17 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT48391WQ-2MOE DCAF17 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT49391WQ-LNA DCAF17 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT46391WQ-RB DCAF17 Human Ribo-modified Inquiry
SIRGT47391WQ-BB DCAF17 Human Backbone-modified Inquiry

Related Products